186 related articles for article (PubMed ID: 16382289)
1. Effect of catheter-based transendocardial delivery of stromal cell-derived factor 1alpha on left ventricular function and perfusion in a porcine model of myocardial infarction.
Koch KC; Schaefer WM; Liehn EA; Rammos C; Mueller D; Schroeder J; Dimassi T; Stopinski T; Weber C
Basic Res Cardiol; 2006 Jan; 101(1):69-77. PubMed ID: 16382289
[TBL] [Abstract][Full Text] [Related]
2. Transplantation of endothelial progenitor cells improves neovascularization and left ventricular function after myocardial infarction in a rat model.
Schuh A; Liehn EA; Sasse A; Hristov M; Sobota R; Kelm M; Merx MW; Weber C
Basic Res Cardiol; 2008 Jan; 103(1):69-77. PubMed ID: 17999028
[TBL] [Abstract][Full Text] [Related]
3. Mesenchymal stem cells over-expressing SDF-1 promote angiogenesis and improve heart function in experimental myocardial infarction in rats.
Tang J; Wang J; Yang J; Kong X; Zheng F; Guo L; Zhang L; Huang Y
Eur J Cardiothorac Surg; 2009 Oct; 36(4):644-50. PubMed ID: 19524448
[TBL] [Abstract][Full Text] [Related]
4. Mobilizing of haematopoietic stem cells to ischemic myocardium by plasmid mediated stromal-cell-derived factor-1alpha (SDF-1alpha) treatment.
Tang YL; Qian K; Zhang YC; Shen L; Phillips MI
Regul Pept; 2005 Feb; 125(1-3):1-8. PubMed ID: 15582707
[TBL] [Abstract][Full Text] [Related]
5. Local delivery of protease-resistant stromal cell derived factor-1 for stem cell recruitment after myocardial infarction.
Segers VF; Tokunou T; Higgins LJ; MacGillivray C; Gannon J; Lee RT
Circulation; 2007 Oct; 116(15):1683-92. PubMed ID: 17875967
[TBL] [Abstract][Full Text] [Related]
6. Stromal cell-derived factor and granulocyte-monocyte colony-stimulating factor form a combined neovasculogenic therapy for ischemic cardiomyopathy.
Woo YJ; Grand TJ; Berry MF; Atluri P; Moise MA; Hsu VM; Cohen J; Fisher O; Burdick J; Taylor M; Zentko S; Liao G; Smith M; Kolakowski S; Jayasankar V; Gardner TJ; Sweeney HL
J Thorac Cardiovasc Surg; 2005 Aug; 130(2):321-9. PubMed ID: 16077394
[TBL] [Abstract][Full Text] [Related]
7. Neovasculogenic therapy to augment perfusion and preserve viability in ischemic cardiomyopathy.
Atluri P; Liao GP; Panlilio CM; Hsu VM; Leskowitz MJ; Morine KJ; Cohen JE; Berry MF; Suarez EE; Murphy DA; Lee WM; Gardner TJ; Sweeney HL; Woo YJ
Ann Thorac Surg; 2006 May; 81(5):1728-36. PubMed ID: 16631663
[TBL] [Abstract][Full Text] [Related]
8. Controlled release of stromal cell-derived factor-1 alpha in situ increases c-kit+ cell homing to the infarcted heart.
Zhang G; Nakamura Y; Wang X; Hu Q; Suggs LJ; Zhang J
Tissue Eng; 2007 Aug; 13(8):2063-71. PubMed ID: 17518719
[TBL] [Abstract][Full Text] [Related]
9. Stem cell mobilization induced by subcutaneous granulocyte-colony stimulating factor to improve cardiac regeneration after acute ST-elevation myocardial infarction: result of the double-blind, randomized, placebo-controlled stem cells in myocardial infarction (STEMMI) trial.
Ripa RS; Jørgensen E; Wang Y; Thune JJ; Nilsson JC; Søndergaard L; Johnsen HE; Køber L; Grande P; Kastrup J
Circulation; 2006 Apr; 113(16):1983-92. PubMed ID: 16531621
[TBL] [Abstract][Full Text] [Related]
10. Intravenous infusion of mesenchymal stem cells enhances regional perfusion and improves ventricular function in a porcine model of myocardial infarction.
Halkos ME; Zhao ZQ; Kerendi F; Wang NP; Jiang R; Schmarkey LS; Martin BJ; Quyyumi AA; Few WL; Kin H; Guyton RA; Vinten-Johansen J
Basic Res Cardiol; 2008 Nov; 103(6):525-36. PubMed ID: 18704259
[TBL] [Abstract][Full Text] [Related]
11. Granulocyte colony-stimulating factor and stem cell factor improve endogenous repair after myocardial infarction.
Kanellakis P; Slater NJ; Du XJ; Bobik A; Curtis DJ
Cardiovasc Res; 2006 Apr; 70(1):117-25. PubMed ID: 16497284
[TBL] [Abstract][Full Text] [Related]
12. Neovascularization and cardiomyocytes regeneration in acute myocardial infarction after bone marrow stromal cell transplantation: comparison of infarct-relative and noninfarct-relative arterial approaches in swine.
Yang ZJ; Ma DC; Wang W; Xu SL; Zhang YQ; Chen B; Zhou F; Zhu TB; Wang LS; Jia EZ; Zhang FM; Cao KJ; Xu ZQ; Ma WZ
Clin Chim Acta; 2007 Jun; 381(2):114-8. PubMed ID: 17400203
[TBL] [Abstract][Full Text] [Related]
13. Mechanisms of improvement of left ventricle remodeling by trans-planting two kinds of autologous bone marrow stem cells in pigs.
Li SR; Qi XY; Hu FL; Zhang JQ; Wang TH; Dang Y; Meng CL; Liu HL; Li YX; Wu D; Dong J; Xun LY; Gao LH; Jin FC
Chin Med J (Engl); 2008 Dec; 121(23):2403-9. PubMed ID: 19102957
[TBL] [Abstract][Full Text] [Related]
14. Intracoronary delivery of umbilical cord blood derived unrestricted somatic stem cells is not suitable to improve LV function after myocardial infarction in swine.
Moelker AD; Baks T; Wever KM; Spitskovsky D; Wielopolski PA; van Beusekom HM; van Geuns RJ; Wnendt S; Duncker DJ; van der Giessen WJ
J Mol Cell Cardiol; 2007 Apr; 42(4):735-45. PubMed ID: 17320899
[TBL] [Abstract][Full Text] [Related]
15. Transplanted human umbilical cord blood mononuclear cells improve left ventricular function through angiogenesis in myocardial infarction.
Hu CH; Wu GF; Wang XQ; Yang YH; Du ZM; He XH; Xiang P
Chin Med J (Engl); 2006 Sep; 119(18):1499-506. PubMed ID: 16996002
[TBL] [Abstract][Full Text] [Related]
16. SDF-1α as a therapeutic stem cell homing factor in myocardial infarction.
Ghadge SK; Mühlstedt S; Ozcelik C; Bader M
Pharmacol Ther; 2011 Jan; 129(1):97-108. PubMed ID: 20965212
[TBL] [Abstract][Full Text] [Related]
17. Effects of Tongxinluo-facilitated cellular cardiomyoplasty with autologous bone marrow-mesenchymal stem cells on postinfarct swine hearts.
Qian HY; Yang YJ; Huang J; Gao RL; Dou KF; Yang GS; Li JJ; Shen R; He ZX; Lu MJ; Zhao SH
Chin Med J (Engl); 2007 Aug; 120(16):1416-25. PubMed ID: 17825171
[TBL] [Abstract][Full Text] [Related]
18. Differential effect of intracoronary infusion of mobilized peripheral blood stem cells by granulocyte colony-stimulating factor on left ventricular function and remodeling in patients with acute myocardial infarction versus old myocardial infarction: the MAGIC Cell-3-DES randomized, controlled trial.
Kang HJ; Lee HY; Na SH; Chang SA; Park KW; Kim HK; Kim SY; Chang HJ; Lee W; Kang WJ; Koo BK; Kim YJ; Lee DS; Sohn DW; Han KS; Oh BH; Park YB; Kim HS
Circulation; 2006 Jul; 114(1 Suppl):I145-51. PubMed ID: 16820564
[TBL] [Abstract][Full Text] [Related]
19. High dose aspirin and left ventricular remodeling after myocardial infarction: aspirin and myocardial infarction.
Adamek A; Hu K; Bayer B; Wagner H; Ertl G; Bauersachs J; Frantz S
Basic Res Cardiol; 2007 Jul; 102(4):334-40. PubMed ID: 17340057
[TBL] [Abstract][Full Text] [Related]
20. Mesothelial cell transplantation in the infarct scar induces neovascularization and improves heart function.
Elmadbouh I; Chen Y; Louedec L; Silberman S; Pouzet B; Meilhac O; Michel JB
Cardiovasc Res; 2005 Nov; 68(2):307-17. PubMed ID: 15979058
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
